Document
EPCLUSA, 214187, Review Proprietary Name Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Proprietary Name Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Product Quality Reviews (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Product Quality Reviews (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review Printed Labeling (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review Printed Labeling (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 214187, Review OfficerEmployee List (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 214187, Review OfficerEmployee List (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 208341, Letter (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 208341, Letter (Orange Book Jun. 10, 2021)
+ More Snippets
Document
EPCLUSA, 208341, Label (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 208341, Label (Orange Book Jun. 10, 2021)
+ More Snippets
Document
IPR2018-00119, No. 1015-33 Exhibit - EPO Decision (P.T.A.B. Jun. 4, 2018)
Cite Document
IPR2018-00119, No. 1015-33 Exhibit - EPO Decision (P.T.A.B. Jun. 4, 2018)
+ More Snippets
Document
IPR2018-00119, No. 3001-32 Exhibit - Certificate of Correction (P.T.A.B. May. 4, 2018)
Cite Document
IPR2018-00119, No. 3001-32 Exhibit - Certificate of Correction (P.T.A.B. May. 4, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2 C Methylcytidine (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2 C Methylcytidine (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2004-18 Exhibit - HARVONI label (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2004-18 Exhibit - HARVONI label (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2002-16 Exhibit - Curing Chronic Hepatitis C The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2002-16 Exhibit - Curing Chronic Hepatitis C The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2017-29 Exhibit - Pro Nucleotides Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 2018...
Cite Document
IPR2018-00120, No. 2017-29 Exhibit - Pro Nucleotides Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2012-26 Exhibit - FDA Approves Gileads Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2012-26 Exhibit - FDA Approves Gileads Hepatitis C Drug (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00120, No. 2015-27 Exhibit - Discovery of a D 2 Deoxy 2 Cmethyluridine Nucleotide Prodrug PSI 7977 for theTreatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00120, No. 2015-27 Exhibit - Discovery of a D 2 Deoxy 2 Cmethyluridine Nucleotide Prodrug PSI 7977 for theTreatment of Hepatitis C Virus (P.T.A.B. Feb. 8, 2018)
+ More Snippets
Document
IPR2018-00119, No. 2002-16 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
Cite Document
IPR2018-00119, No. 2002-16 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 8, 2018)
+ More Snippets